Allegion (NYSE:ALLE) Price Target Lowered to $155.00 at Wells Fargo & Company
by Tristan Rich · The Markets DailyAllegion (NYSE:ALLE – Get Free Report) had its price objective dropped by equities researchers at Wells Fargo & Company from $175.00 to $155.00 in a research report issued to clients and investors on Wednesday,Benzinga reports. The brokerage currently has an “equal weight” rating on the scientific and technical instruments company’s stock. Wells Fargo & Company‘s price objective indicates a potential upside of 7.08% from the stock’s previous close.
ALLE has been the topic of several other research reports. JPMorgan Chase & Co. lowered their target price on shares of Allegion from $190.00 to $180.00 and set an “overweight” rating on the stock in a report on Wednesday, February 18th. Barclays reduced their price objective on shares of Allegion from $180.00 to $176.00 and set an “equal weight” rating for the company in a research report on Monday, February 23rd. Finally, Weiss Ratings reiterated a “buy (b)” rating on shares of Allegion in a research report on Wednesday, January 21st. Three analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $172.50.
Check Out Our Latest Analysis on ALLE
Allegion Stock Down 0.4%
Shares of ALLE traded down $0.54 during midday trading on Wednesday, reaching $144.75. The stock had a trading volume of 228,149 shares, compared to its average volume of 893,633. The company has a market cap of $12.47 billion, a price-to-earnings ratio of 19.45, a PEG ratio of 3.09 and a beta of 1.03. The company’s fifty day simple moving average is $159.22 and its two-hundred day simple moving average is $164.41. Allegion has a 1-year low of $116.57 and a 1-year high of $183.11. The company has a debt-to-equity ratio of 0.96, a current ratio of 1.84 and a quick ratio of 1.16.
Allegion (NYSE:ALLE – Get Free Report) last announced its quarterly earnings results on Tuesday, February 17th. The scientific and technical instruments company reported $1.94 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.01 by ($0.07). The business had revenue of $1.03 billion during the quarter, compared to analyst estimates of $1.04 billion. Allegion had a net margin of 15.83% and a return on equity of 38.06%. The business’s revenue for the quarter was up 9.3% compared to the same quarter last year. During the same period last year, the company earned $1.86 earnings per share. Allegion has set its FY 2026 guidance at 8.700-8.900 EPS. Equities research analysts expect that Allegion will post 7.77 earnings per share for the current year.
Insider Buying and Selling
In related news, Director Steven Mizell sold 1,000 shares of the stock in a transaction on Thursday, February 19th. The stock was sold at an average price of $161.51, for a total transaction of $161,510.00. Following the sale, the director owned 4,915 shares of the company’s stock, valued at $793,821.65. This trade represents a 16.91% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Sue Main bought 2,000 shares of Allegion stock in a transaction on Wednesday, March 11th. The stock was purchased at an average price of $149.61 per share, for a total transaction of $299,220.00. Following the completion of the acquisition, the director owned 2,000 shares in the company, valued at $299,220. This represents a ∞ increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Company insiders own 0.23% of the company’s stock.
Hedge Funds Weigh In On Allegion
Large investors have recently bought and sold shares of the stock. Hsbc Holdings PLC raised its stake in shares of Allegion by 2.9% in the 4th quarter. Hsbc Holdings PLC now owns 34,469 shares of the scientific and technical instruments company’s stock valued at $5,527,000 after acquiring an additional 956 shares during the period. Rockefeller Capital Management L.P. increased its holdings in Allegion by 16.3% in the 4th quarter. Rockefeller Capital Management L.P. now owns 19,372 shares of the scientific and technical instruments company’s stock valued at $3,085,000 after purchasing an additional 2,717 shares in the last quarter. PEAK6 LLC acquired a new position in shares of Allegion during the fourth quarter worth about $366,000. Corient Private Wealth LLC lifted its stake in shares of Allegion by 2.3% during the fourth quarter. Corient Private Wealth LLC now owns 7,413 shares of the scientific and technical instruments company’s stock worth $1,180,000 after purchasing an additional 170 shares in the last quarter. Finally, Compound Planning Inc. boosted its position in shares of Allegion by 11.5% in the fourth quarter. Compound Planning Inc. now owns 2,515 shares of the scientific and technical instruments company’s stock worth $400,000 after buying an additional 259 shares during the period. Hedge funds and other institutional investors own 92.21% of the company’s stock.
Allegion Company Profile
Allegion plc (NYSE: ALLE) is a global provider of security products and solutions focused on ensuring the safety and security of people and property. The company was formed in December 2013 through a corporate spin-off from Ingersoll Rand and is headquartered in Dublin, Ireland. Allegion’s core mission is to deliver innovative mechanical and electronic access control systems for a wide range of end markets, including commercial buildings, residential properties, institutional facilities, and industrial sites.
The company’s product portfolio spans mechanical locksets, door closers, exit devices, key systems and cylinders, as well as a growing suite of electronic and smart access control offerings.